|Bid||11.76 x 1000|
|Ask||11.62 x 1800|
|Day's Range||11.30 - 12.20|
|52 Week Range||5.28 - 18.39|
|Beta (3Y Monthly)||1.13|
|PE Ratio (TTM)||575.50|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Will Febbo has been the CEO of OptimizeRx Corporation (NASDAQ:OPRX) since 2016. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider gro...
OptimizeRx Corp is a technology solutions company serving the healthcare industry. OptimizeRx Corp had annual average EBITDA growth of 23.90% over the past ten years. Warning! GuruFocus has detected 2 Warning Signs with OPRX.
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! While some investors are already well versed in financial metricsRead More...
OptimizeRx Corp., a digital health messaging company, for the pharmaceutical industry, has formed a partnership with Birmingham's IllumiCare. IllumiCare’s Smart Ribbon platform will feature a new app from OptimizeRx that presents drug-savings opportunities that health providers and the clinical care team can distribute to the patient directly at the point-of-care. “Our collaboration with OptimizeRx will enable providers to be better stewards of health care spending,” said G.T. LaBorde, CEO of IllumiCare. “Our Smart Ribbon technology, accessible within the provider’s workflow in the electronic health record (EHR), will give providers easy access to render coupons, savings opportunities or alternate drug choices to best support the patient.” IllumiCare offers a non-intrusive electronic medical record tool that provides clinicians with patient-specific information ranging from real-time costs of procedures to predicted patient harm data.
If you own shares in OptimizeRx Corporation (NASDAQ:OPRX) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of Read More...
The big shareholder groups in OptimizeRx Corporation (NASDAQ:OPRX) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership Read More...
OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zero-debt allows substantial financial flexibility, especially for small-cap companies like OptimizeRx Corporation (NASDAQ:OPRX), as the company does not have to adhere to strict debt covenants. However, it also faces higher Read More...
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.